$SMR

NuScale Stock Decays After Q2 Revenues Miss Estimates - NuScale Power (NYSE:SMR)

NuScale Power (SMR) shares fell 5.76% to $8.84 in extended trading after Q2 results. The company reported a 13 cents per share loss, matching consensus, but revenue of $75,000 missed the $8.91 million estimate, according to Benzinga Pro. R&D expenses rose $6.6 million year over year for the quarter ended June 30, 2026.

Original reporting
Published Aug 5, 2026, 11:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 12:10 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SMR
Bearish
medium confidence
Mentioned
$SMR
Relevance
8/10
alphai data visualization · based on benzinga.com
Decision brief

The 30-second read

$SMRBearishMed
01

Why it matters

Revenue missed consensus and the stock sold off in extended trading, suggesting investors are focused on commercialization progress and near-term monetization.

02

Market read

SMR’s Q2 revenue miss versus consensus is the actionable catalyst driving immediate price pressure.

03

What to watch

No guidance, cash runway, or order/backlog detail is provided, so traders may be missing whether the miss reflects timing rather than deteriorating demand.

Relevance 8/10Novelty 6/10Timing: after-hours/extended trading reaction to Q2 results (Aug 5)

Background

The piece summarizes NuScale’s Q2 results versus consensus and notes R&D expense growth.

Company-level read

Ticker impact

$SMRBearishMedium confidence
Context

NuScale reported Q2 revenue of $75,000, missing the $8.91M consensus, and shares fell 5.76% in extended trading.

Expected impact

Bearish near-term bias, with follow-through risk if investors treat the revenue miss as demand or commercialization slippage.

Evidence & confidence

The article provides a concrete Q2 revenue miss versus consensus and ties it to a same-session stock decline in extended trading, but lacks guidance or balance-sheet details to gauge longer-term fundamentals.

Market effects

Weak reported revenue in a nuclear developer can pressure sentiment across small-cap clean-power/nuclear names, especially those reliant on near-term commercialization milestones.

Primarily US small-cap growth sentiment; limited direct regional spillover implied by the article.

Low global relevance from this single-company revenue miss, absent broader policy or sector-wide developments.

Counterpoint

The article shows a revenue miss but does not discuss backlog, contract awards, or cash burn; the market may be overreacting to a single quarter’s revenue timing.

Key entities

  • NuScale Power

    Subject of the article, with Q2 revenue miss and extended-trading decline reported.

  • John Hopkins

    CEO quoted on clean power demand and technology delivery timing.

Related articles

$STLAMed

Why Did STLA, OLLI, SMR Stocks Hit 52-Week Lows Today?

Stellantis (STLA), Ollie’s Bargain Outlet (OLLI) and NuScale Power (SMR) hit fresh 52-week lows amid worries about slower growth, higher costs and uncertain timelines. STLA fell to $5.33 after a JPMorgan downgrade to Neutral and a cut to a $6.85 target. OLLI slid to $61.61 after JPMorgan cut its target to $70. SMR touched $8.55 after a larger-than-expected Q1 loss and revenue decline.

$SMRLow

NUSCALE POWER Corp (SMR): Results of Operations and Financial Condition

NUSCALE POWER Corp (SMR) filed an SEC Form 8-K — Results of Operations and Financial Condition. smr-20260805 0001822966 FALSE 0001822966 2026-08-05 2026-08-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________ FORM 8-K __________________________________ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES E

$SMRMed

Why NuScale Power Stock Fell 29% in the First Half of 2026

NuScale Power shares fell 29.2% in the first half of 2026, according to S&P Global Market Intelligence. The article cites concerns about potential delays to NuScale’s Romania project, a $507.4 million milestone payment to ENTRA1 Energy, rising operating loss to $690 million, and Q1 revenue dropping to $0.5 million. It also notes Fluor exited NuScale by April 2026.

$XEMed

XE Vs SMR: Analysts See One Small Nuclear Stock With Nearly Double The Upside

Analysts highlighted X-Energy (XE) versus NuScale Power (SMR) as small modular nuclear plays amid rising power demand. X-Energy joined the DOE Genesis Mission’s Prometheus initiative, investing $10M and contributing its Xe-100 reactor and TRISO-X fuel. Koyfin data show XE avg 12-month target $37.86 versus SMR $14.57. Barclays cut SMR to $11; Citi raised to $7.50.